Elekta AB (publ) (EKTAY) Stock Forecast & Price Target

$7.95

0.00 (0.00%)

(As of 12/8/2023 ET)

Compare

Today's Range: $7.92
▼
$7.99
50-Day Range: $6.60
▼
$8.54
52-Week Range: $5.54
▼
$8.65

Volume: 3,845 shs
Average Volume: 5,009 shs
Market Capitalization: $3.05 billion

P/E Ratio: 28.39
Dividend Yield: 1.89%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Dividend Earnings Financials Headlines Short Interest

Elekta AB (publ) Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Reduce
Based on 7 Analyst Ratings

Analysts' Consensus Price Target

N/A

Type	Current Forecast 12/9/22 to 12/9/23	1 Month Ago 11/9/22 to 11/9/23	3 Months Ago 9/10/22 to 9/10/23	1 Year Ago 12/9/21 to 12/9/22
Consensus Rating	Reduce	Reduce	Hold	Sell
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	0 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	4 Sell rating(s)	4 Sell rating(s)	3 Sell rating(s)	3 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Predicted Upside	N/A	N/A	N/A	N/A

Get Elekta AB (publ) Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EKTAY and its competitors with MarketBeat's FREE daily newsletter.

EKTAY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EKTAY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Elekta AB (publ) Stock vs. The Competition

Type	Elekta AB (publ)	Medical Companies	S&P 500
Consensus Rating Score	1.86	2.68	2.49
Consensus Rating	Reduce	Moderate Buy	Hold
Predicted Upside		729.57% Upside	3,819.09% Upside
News Sentiment Rating	Very Positive News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target
10/5/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Underweight
7/12/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sell
3/7/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
2/14/2023	AlphaValue Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy
1/31/2023	Nordea Equity Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
1/12/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Underweight ➝ Underweight	SEK 63 ➝ SEK 62
12/12/2022	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sell

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 12:30 PM ET.

EKTAY Price Target - Frequently Asked Questions

What is Elekta AB (publ)'s consensus rating?: According to the issued ratings of 7 analysts in the last year, the consensus rating for Elekta AB (publ) stock is Reduce based on the current 4 sell ratings and 3 buy ratings for EKTAYthe . Learn more on EKTAY's analyst rating history.
Do Wall Street analysts like Elekta AB (publ) more than its competitors?: Analysts like Elekta AB (publ) less than other Medical companies. The consensus rating for Elekta AB (publ) is Reduce while the average consensus rating for medical companies is Moderate Buy. Learn more on how EKTAY compares to other companies.
What analysts cover Elekta AB (publ)?: Elekta AB (publ) has been rated by Barclays in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (OTCMKTS:EKTAY) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial